Opioid agonist therapy

[10][11] The amount of oral methadone a patient will require is dependent on the amount and power of opioids they consumed prior to initiating treatment, with an assessment in the mid-2000s (prior to the widespread introduction of fentanyl into street heroin supplies in the US) finding that 1 gram of street heroin is roughly equivalent to 50 to 80 mg of methadone.Since the formulations are not as viscous as the 1 mg/1ml mixture, they are more prone to misuse since they are easier to inject, and due to the high risk of overdose if diverted to an individual not accustomed to such a large dose.[13] Methadone maintenance has been termed "a first step toward social rehabilitation" because it increases the retention of patients in treatment, relieves them from the need to find, buy, and use multiple daily doses of street opioids, and offers a legal medical alternative.[15][16][17] Methadone maintenance generally requires patients to visit the dispensing or dosing clinic daily, in accordance with state-controlled substance laws.Methadone, when administered at constant daily milligram doses, will stabilize patients so they feel a "high" from it and will not require additional street opioids.[21] Addiction is widespread among users and can typically be seen through symptoms such as intense cravings, rejection of previously enjoyed activities, and struggling to fulfill responsibilities due to opioid use.[23] There are numerous psychological variables that hold the capacity to influence the effectiveness of opioid agonist therapy (OAT), as explained in Daniel Michael Doleys's 2017 narrative review.[23] Certain patient characteristics, such as distress intolerance, can result in increased opioid misuse to obtain relief from one's chronic pain.[24] Most treatment facilities, such as rehabilitation or sobering centers, do not offer OAT, nor do they accept patients who are already receiving Opioid Agonist Therapy.[24] Due to risks associated with intravenous drug use, such as infections and blood borne illnesses, access to post-acute care is critical.[24] Advocates identify the bureaucratic red tape surrounding the prescription and administration of opioid agonists as potential obstructions to fair accessible medical care.[24] Rahul Gupta, director of the White House Office of National Drug Control Policy, identified stigma among doctors as a barrier that patients with OUD.[29] In England and Wales, criminal justice drugs workers employed by the 'Drug Interventions Programme' are based in most arrest suites nationwide.Heroin and crack cocaine users are identified either by mandatory urine tests, or by cell sweeps and face-to-face discussions with arrestees.This line of work originated in the mid to late 1990s, as large-scale studies identified significant levels of heroin and crack cocaine use in populations of arrestees.[31] These studies, along with others,[32][33][34] were taken on by Tony Blair whilst still Shadow Home Secretary, as Conservative policy regarding drug misuse was relatively undeveloped.Blair disseminated a press release in 1994 entitled 'Drugs: the Need for Action', claiming that drug misuse caused £20bn of money-related crimes each year.This report was dismissed by the Conservative Secretary of State for the Home Department as 'four pages of hot waffle against the Government, with three miserable paragraphs at the end'.
prescribedopioid agonistsOpioid use disordermethadoneheroinopioidswithdrawalcognitive improvementHIV transmissionphysiologyenvironmental surroundingsquality of lifebuprenorphineopioidligandmoleculeopioid receptorThe mesolimbic systemdopamineopioid withdrawalopioid agonistcompetitive antagonismTherapeuticnaltrexoneNarcotics AnonymousUnited States Food and Drug Administrationchronic painpain-killerAddictionconditioningenvironmental cuesdistress intolerancepsychosocialCounselingUnited StatesstigmatizedAmericans with Disabilities ActRahul GuptaWhite House Office of National Drug Control PolicyDrug Interventions ProgrammecocaineTony BlairSecretary of State for the Home DepartmentHarm reductionStimulant maintenanceMorbidity and Mortality Weekly ReportCalifornia Alcohol and Drug Programs